Ginkgo Bioworks DNA Restructuring Costs And Asset Impairment Charges
Restructuring Costs And Asset Impairment Charges at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCostsAndAssetImpairmentCharges.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's restructuring costs and asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's restructuring costs and asset impairment charges?
- Ginkgo Bioworks (DNA) reported restructuring costs and asset impairment charges of $0 in Q1 2026.
- How has Ginkgo Bioworks's restructuring costs and asset impairment charges changed year-over-year?
- Ginkgo Bioworks's restructuring costs and asset impairment charges decreased by 100.0% year-over-year, from $4.47M to $0.
- What does restructuring costs and asset impairment charges mean?
- This metric captures expenses related to organizational realignment, including severance, facility closures, and the write-down of long-lived assets. It highlights the financial impact of efforts to streamline operations or pivot business models. High levels of these costs often indicate significant operational transformation or distress.